Project Addendum No 01 zu einer interventionellen Studie

Basic data

Title:
Addendum No 01 zu einer interventionellen Studie
Duration:
01/11/2014 to 31/10/2020
Abstract / short description:
A phase 3, multicenter, randomized, double-blind, placebo and active comparator-controlled study evaluating the efficacy and safety of Guselkumab with randomized withdrawal and retreatment
Keywords:
dermatology
Dermatologie
clinical trial
klinische Studie
psoriasis therapeutics
Psoriasis Therapeutika
psoriasis
Schuppenflechte

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Neuss, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.